¼¼°èÀÇ MRI Á¶¿µÁ¦ ½ÃÀå º¸°í¼­(2025³â)
MRI Contrast Media Global Market Report 2025
»óǰÄÚµå : 1693321
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,496,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,390,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,284,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

MRI Á¶¿µÁ¦ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â 6.1%ÀÇ CAGR·Î 21¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¾Ï ȯÀÚ Áõ°¡, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, R&D ÅõÀÚ ¹× Ȱµ¿ Áõ°¡, ÀÇ·á ÁöÃâ Áõ°¡, MRI ÀÀ¿ë ÇÁ·Î±×·¥ È®´ë¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â °øµ¿¿¬±¸ÀÇ ¹ßÀü, ±â¼ú ¹ßÀü, Á¦Ç° Çõ½Å, º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀÎ Á¶¿µÁ¦ °³¹ß, Á¦¾àȸ»ç ¹× »ý¸í°øÇÐ ±â¾÷ÀÇ Á¦Ç° Çõ½Å µîÀÌ ÀÖ½À´Ï´Ù.

¾Ï ȯÀÚÀÇ Áõ°¡´Â MRI Á¶¿µÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Ï ȯÀÚ Áõ°¡´Â Àα¸Åë°èÇÐÀû º¯È­, »ýȰ½À°ü ¼±ÅÃ, ȯ°æÀû ¿µÇâ, À¯ÀüÀû ¼ÒÀÎ, ÀÇ·á±â¼úÀÇ ¹ßÀü µî ´Ù¾çÇÑ ¿äÀο¡ ±âÀÎÇϸç, MRI °Ë»ç´Â °¡µ¹¸®´½ ±â¹Ý È­ÇÕ¹°À» Æ÷ÇÔÇÑ Á¶¿µÁ¦¸¦ ÀÌ¿ëÇÏ¿© Á¶Á÷ÀÇ ÀÚ±âÀû Ư¼ºÀ» º¯È­½ÃÄÑ °¡½Ã¼ºÀ» Çâ»ó½Ã۰í, Á¾¾çÀÇ Å½Áö, Å©±â °áÁ¤, Ư¼ºÈ­, ÁÖº¯ Á¶Á÷ ħÀ±À» Æò°¡ÇÕ´Ï´Ù. Å©±â °áÁ¤, Ư¼ºÈ­¸¦ Áö¿øÇϸç ÁÖº¯ Á¶Á÷À¸·ÎÀÇ Ä§À±À» Æò°¡ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)°¡ 2024³â 2¿ù ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, 2022³â Àü ¼¼°è ½Å±Ô ¾Ï ȯÀÚ ¼ö´Â 2,000¸¸ ¸íÀ¸·Î ±ÞÁõÇÏ¿© 970¸¸ ¸íÀÌ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø¿¡ µû¸£¸é, 2050³â±îÁö ¾Ï ȯÀÚ ¼ö´Â Å©°Ô Áõ°¡ÇÏ¿© 2022³â ÃßÁ¤ ȯÀÚ ¼ö 2,000¸¸ ¸í¿¡ ºñÇØ 77% Áõ°¡ÇÑ 3,500¸¸ ¸í ÀÌ»óÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µû¶ó¼­ ¾Ï ¹ß»ý·ü Áõ°¡´Â MRI Á¶¿µÁ¦ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

MRI Á¶¿µÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ´ëȯÇü °¡µ¹¸®´½°è Á¶¿µÁ¦(GBCA)¿Í °°Àº ÷´Ü Á¦Ç°ÀÇ °³¹ß ¹× ÆÇ¸Å¿¡ Àü·«ÀûÀ¸·Î ÁýÁßÇϰí ÀÖÀ¸¸ç, MRI ¿µ»ó Áø´ÜÀÇ Áø´Ü ´É·Â°ú ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ´ëȯÇü °¡µ¹¸®´½°è Á¶¿µÁ¦(GBCA)´Â ÀÇ·á¿ë ¿µ»ó, ƯÈ÷ ÀÚ±â°ø¸í¿µ»ó(MRI)¿¡ »ç¿ëµÇ´Â Á¶¿µÁ¦ Ä«Å×°í¸®¸¦ ´ëÇ¥ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 2¿ù ÇÁ¶û½º¿¡ º»»ç¸¦ µÐ MRI Á¶¿µÁ¦ °ø±Þ¾÷üÀÎ GuerbetÀº Elucirem(°¡µµÇÇŬ·¹³î) ÁÖ»çÁ¦¸¦ ¹ßÇ¥Çߴµ¥, Elucirem(°¡µµÇÇŬ·¹³î) ÁÖ»çÁ¦´Â ¾ÈÁ¤¼ºÀÌ ³ôÀº ´ëȯÇü °¡µ¹¸®´½°è Á¶¿µÁ¦(GBCA)¶ó´Â Ư¡ÀÌ ÀÖÀ¸¸ç, MRI¿¡¼­ µ¿±Þ ÃÖ°íÀÇ À̿ϼºÀ» ÀÚ¶ûÇÕ´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ °¡µµÇÇŬ·¹³î Á¦Á¦´Â ÁßÃ߽Űæ°è ¹× ½ÅüÀÇ ´Ù¾çÇÑ ºÎÀ§¿¡¼­ ºñÁ¤»óÀûÀÎ Ç÷°üÀ» °¡Áø º´º¯ÀÇ °ËÃâ ¹× ½Ã°¢È­¿¡ Ź¿ùÇÑ È¿°ú¸¦ ³ªÅ¸³À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

MRI contrast media refers to substances utilized in magnetic resonance imaging (MRI) to heighten the visibility of internal body structures. These contrast agents function by modifying the magnetic properties of tissues, thereby enhancing the contrast in resultant images.

The primary MRI contrast media products include extracellular contrast agents, blood-pool agents, and hepatobiliary agents. Extracellular contrast agents are employed in MRI to augment the visibility of internal body structures. They find application in diagnosing various conditions such as neurological disorders, musculoskeletal disorders, cardiovascular disorders, cancer detection, and more. These products are utilized by a range of end-users including hospitals, diagnostic and imaging centers, research institutes, and others.

The MRI contrast media market research report is one of a series of new reports from The Business Research Company that provides MRI contrast media market statistics, including MRI contrast media industry global market size, regional shares, competitors with an MRI contrast media market share, detailed MRI contrast media market segments, market trends, and opportunities, and any further data you may need to thrive in the MRI contrast media industry. This MRI contrast media market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mri contrast media market size has grown strongly in recent years. It will grow from $1.56 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising demand for early diagnosis, increasing demand for diagnostic accuracy and patient outcomes, increased public awareness, development of combination imaging modalities, identification of novel use cases for contrast agents.

The mri contrast media market size is expected to see strong growth in the next few years. It will grow to $2.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rise in cancer cases, growing prevalence of chronic diseases, increasing research and development investment and activities, increasing healthcare expenditure, expanding applications of MRI. Major trends in the forecast period include advancement with collaborative research, technological advancements, product innovation, development of safer and more effective contrast agents, product innovations by pharmaceutical and biotechnology companies.

The anticipated increase in cancer cases is expected to drive growth within the MRI contrast media market. This rise in cancer cases is attributed to a multitude of factors, including demographic shifts, lifestyle choices, environmental influences, genetic predispositions, and advancements in healthcare practices. MRI scans utilize contrast agents containing gadolinium-based compounds to enhance visualization by modifying tissue magnetic properties, aiding in the detection, sizing, and characterization of tumors, as well as evaluating their invasion into surrounding tissues. For instance, a report published by the World Health Organization (WHO) in February 2024 revealed that the global estimated number of new cancer cases surged to 20 million in 2022, resulting in 9.7 million deaths. Projections indicate a substantial increase in cancer cases by 2050, with an anticipated 77% rise to over 35 million new cases, compared to the estimated 20 million cases in 2022. Hence, the mounting incidence of cancer serves as a driving force behind the expansion of the MRI contrast media market.

Key players in the MRI contrast media market are strategically focused on developing and distributing advanced products, such as macrocyclic gadolinium-based contrast agents (GBCA), to augment the diagnostic capabilities and safety profile of MRI imaging procedures. Macrocyclic gadolinium-based contrast agents (GBCA) represent a category of contrast agents utilized in medical imaging, particularly in magnetic resonance imaging (MRI). For instance, in February 2023, Guerbet, a France-based provider of MRI contrast media, unveiled the Elucirem (gadopiclenol) injection. Distinguished by its highly stable macrocyclic gadolinium-based contrast agent (GBCA), Elucirem (gadopiclenol) injection boasts the highest relaxivity in its class for MRI. This innovative formulation of gadopiclenol demonstrates exceptional efficacy in detecting and visualizing lesions with abnormal vascularity across various regions of the central nervous system and the body.

In March 2023, Bracco Imaging S.p.A., an Italy-based healthcare company, concluded the acquisition of the remaining 49% stake in Bracco-Eisai Co. Ltd. for an undisclosed sum. This strategic move is aimed at facilitating swift and adaptable responses to the evolving healthcare industry landscape, with a focus on achieving sustainable contributions to patient care through product utilization. Bracco-Eisai Co. Ltd., based in Japan, is recognized for its provision of MRI contrast media, contributing to Bracco Imaging S.p.A.'s comprehensive portfolio of healthcare solutions.

Major companies operating in the MRI contrast media market are Bayer AG, GE Healthcare Technologies Inc., Fresenius Kabi AG, Fujifilm Holdings Corporation, JB Chemicals and Pharmaceuticals Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd., Bracco S.p.A., Miltenyi Biotec B.V. & Co. KG, Lantheus Medical Imaging Inc., Guerbet LLC, Curium Pharma, Spago Nanomedical AB, AMAG Pharmaceuticals Inc., Nanopet Pharma GmbH, Trivitron Healthcare, Beijing Beilu Pharmaceuticals Company Limited, Unijules Life Sciences Ltd., Taejoon Pharm Co. Ltd., Mediso USA LLC, Nano Therapeutics Pvt. Ltd., Livealth Biopharma Pvt Ltd., BioPAL Inc., Vitalquan LLC, Shubhra Biotech Pvt Ltd., Rege Imaging & Cine Films Private Limited, Polarean Inc.

North America was the largest region in the MRI contrast media market in 2024. The regions covered in the mri contrast media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mri contrast media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The MRI contrast media market consists of sales of gadopentetate dimeglumine (Gd-DTPA), gadodiamide, diatrizoate, and gadoversetamide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

MRI Contrast Media Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mri contrast media market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for mri contrast media ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mri contrast media market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. MRI Contrast Media Market Characteristics

3. MRI Contrast Media Market Trends And Strategies

4. MRI Contrast Media Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global MRI Contrast Media Growth Analysis And Strategic Analysis Framework

6. MRI Contrast Media Market Segmentation

7. MRI Contrast Media Market Regional And Country Analysis

8. Asia-Pacific MRI Contrast Media Market

9. China MRI Contrast Media Market

10. India MRI Contrast Media Market

11. Japan MRI Contrast Media Market

12. Australia MRI Contrast Media Market

13. Indonesia MRI Contrast Media Market

14. South Korea MRI Contrast Media Market

15. Western Europe MRI Contrast Media Market

16. UK MRI Contrast Media Market

17. Germany MRI Contrast Media Market

18. France MRI Contrast Media Market

19. Italy MRI Contrast Media Market

20. Spain MRI Contrast Media Market

21. Eastern Europe MRI Contrast Media Market

22. Russia MRI Contrast Media Market

23. North America MRI Contrast Media Market

24. USA MRI Contrast Media Market

25. Canada MRI Contrast Media Market

26. South America MRI Contrast Media Market

27. Brazil MRI Contrast Media Market

28. Middle East MRI Contrast Media Market

29. Africa MRI Contrast Media Market

30. MRI Contrast Media Market Competitive Landscape And Company Profiles

31. MRI Contrast Media Market Other Major And Innovative Companies

32. Global MRI Contrast Media Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The MRI Contrast Media Market

34. Recent Developments In The MRI Contrast Media Market

35. MRI Contrast Media Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â